Thirty-seven adult patients with acute lymphoblastic leukemia were treated with a protocol called HEAV'D including Adriamycin, Vincristine, L-Asparaginase, Cyclophosphamide and Dexamethasone. The complete remission rate was 70 per cent. The median duration of remission was more than 30 months. Patie
Acute lymphoblastic leukemia in adults
β Scribed by Mark R. Litzow
- Book ID
- 107531637
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 291 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1527-2729
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Recent treatment strategies in adult ALL mainly include (1) intensification of induction and consolidation chemotherapy, (2) molecular targeting, particularly in Ph/bcr abl pos-ALL, (3) antibody therapy and (4) extension of stem cell transplantation (SCT). New diagnostic tools are used to refine def
To the Editor: Blast cells of <2% of cases of pediatric B-progenitor cell
## Abstract The clinical outlook for adults with acute lymphoblastic leukemia (ALL) has Improved with the use of intensive chemotherapy. Complete remissions (CR) are achieved in 80% of adults but the majority relapse on maintenance chemotherapy and a few exhibit primary resistance to induction ther